• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Epizyme, Inc. (EPZM)

    -NasdaqGS
    19.98 Up 1.62(8.82%) Dec 19, 4:00PM EST
    |After Hours : 19.98 0.00 (0.00%) Dec 19, 5:00PM EST
    Add to Portfolio
    Prev Close:18.36
    Open:18.45
    Bid:1.00 x 100
    Ask:N/A
    1y Target Est:41.67
    Beta:3.513
    Earnings Date:Feb 25 - Mar 2 (Est.)
    Day's Range:18.45 - 20.07
    52wk Range:16.51 - 41.23
    Volume:1,758,370
    Avg Vol (3m):363,725
    Market Cap:682.58M
    P/E (ttm):N/A
    EPS (ttm):-0.77
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for EPZM

    Comparison

    Symbol% ChgMkt Cap
    EPZMUp 8.82%682.58M
    GSKUp 0.14%104.21B
    NVSUp 0.04%228.83B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.31
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.75
    Quarterly EPS Est (Dec-14) :-0.53
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Epizyme, Inc., a clinical stage biopharmaceutical company, discovers and develops personalized therapeutics for patients with genetically defined cancers. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback